Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,069 public trials 1,836 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, Not Recruiting

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

NCT04180371

Conditions
Adnexal Diseases, Advanced Solid Tumor Historically Known for High EphA2 Expression, Breast Diseases, +49 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. Encinitas, California, United States
  • University of California - Irvine Medical Center Orange, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan Extension

NCT06212752

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Fujita Health University ( Site 4406) Toyoake, Aichi-ken, Japan
  • Kurume University Hospital ( Site 4412) Kurume, Fukuoka, Japan
  • Gunma Prefectural Cancer Center ( Site 4416) Otashi, Gunma, Japan
  • National Hospital Organization Hokkaido Cancer Center ( Site 4415) Sapporo, Hokkaido, Japan
View all 18 locations
View Trial Details
Active, Not Recruiting

CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer

NCT02955290

Conditions
Advanced Head and Neck Squamous Cell Carcinoma, Advanced Squamous Non-Small Cell Lung Carcinoma, Bronchial Neoplasms, +29 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • St. Francis Hospital Roslyn, New York, United States
  • Good Samaritan Hospital West Islip, New York, United States
View Trial Details
Active, Not Recruiting

Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer

NCT00264602

Conditions
Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer

NCT03672773

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
Locations
  • CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • St. Joseph Heritage Healthcare Fullerton, California, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Orlando Health, Inc. d/b/a Orlando Health UF Health Center Orlando, Florida, United States
View Trial Details
Active, Not Recruiting

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

NCT03539536

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • University of South Alabama /ID# 212939 Mobile, Alabama, United States
  • Mayo Clinic Arizona /ID# 218550 Phoenix, Arizona, United States
  • Highlands Oncology Group, PA /ID# 215600 Springdale, Arkansas, United States
  • University of California, Los Angeles /ID# 203219 Los Angeles, California, United States
View all 252 locations
View Trial Details

Related conditions